Novocure Ltd (NVCR)

R&D to Revenue

34.26%

Fiscal year · Period ending:

NVCR logo

NVCR R&D to Revenue

Latest reported34.26%
NVCR FY R&D/Revenue (335.91% → 34.26%)
High-resolution chart · PNG

NVCR r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Novocure Ltd R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
34.2631%
34.6395%
43.7945%
38.3172%
37.6245%
26.7029%
22.4876%
20.3871%
21.524%
50.0277%
132.2211%
260.6908%
335.9108%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.